Aberdeen Asset Management (LON:ADN) Rating Reaffirmed
Recently, In a very recent research note revealed to clients on Tuesday, 1 December, Aberdeen Asset Management (LON:ADN) shares have had their “Neutral” Rating reaffirmed by professional analysts at Citigroup, who currently has a GBX 300.00 target on firm. This target by Citigroup means the possibile downside of -3.97% from the previous close.
From a total of 17 analysts covering Aberdeen Asset Management PLC (LON:ADN) stock, 3 rate it a ”Buy”, 5 a “Sell”, and 10 a ”Hold”. This means that 17% of the ratings are positive. The highest target price is GBX 430 while the lowest target price is GBX 260. The mean of all analyst targets is GBX 342.24 with a 14.63% above today’s (GBX 315.14) stock price. Aberdeen Asset Management PLC was the topic of 45 analyst reports since July 23, 2015 according to the firm StockzIntelligence Inc. Beaufort Securities maintained shares on December 1 with “Buy” rating. JP Morgan maintained shares with “Neutral” rating and GBX 315 target share price in a report from a December 1. Jefferies maintained ADN stock in a recent report from December 1 with “Hold” rating. Numis Securities maintained the rating on November 30. Numis Securities has a “Hold” rating and a GBX 320 price target on shares. Finally, Barclays Capital maintained the stock with “Equal Weight” rating in a report issued on a December 1.
The stock decreased 1.33% or GBX 4.26 on December 1, striking GBX 315.14. Approximately 5.76 million shares of stock traded hands or 63.64% up from the average. Aberdeen Asset Management plc (LON:ADN) has declined 31.03% since May 4, 2015 and is downtrending. It has underperformed by 29.41% the S&P500.
Aberdeen Asset Management PLC is United Kingdom asset management company. The company has a market cap of 4.35 billion GBP. The Firm manages assets for both institutional and retail clients. It has 13.84 P/E ratio. The firm invests across the four main asset classes of equity, fixed income, property and alternative investment strategies.